ABOUT US | SERVICES | SUBSCRIPTIONS | LOGIN | SIGNUP
SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community
MARKETS » MOBILE Commerce HTML5 WebRTC
HOT TOPICS » VIDEO MANAGED SERVICES WEARABLE TECH WORLD NETWORK MANAGEMENT

TMC NEWS

TMCNET eNEWSLETTER SIGNUP

SUBMIT
Hot Stock: BioCryst Pharmaceuticals, Shares Gain 25.0% (BCRX)
[November 30, 2012]

Hot Stock: BioCryst Pharmaceuticals, Shares Gain 25.0% (BCRX)

Nov 30, 2012 (SmarTrend(R) Spotlight via COMTEX) -- BioCryst Pharmaceuticals (NASDAQ:BCRX) is one of today's best performing low-priced stocks, up 25.0% to $2.00 on 4.3x average daily volume. BioCryst Pharmaceuticals has traded 2.9 million shares thus far today, vs. average volume of 676,000 shares per day. The stock has outperformed the Dow (25.0% to the Dow's 0.0%) and outperformed the S&P 500 (25.0% to the S&P's -0.1%) during today's trading.

BioCryst Pharmaceuticals, Inc., a biopharmaceutical company, discovers and designs novel small-molecule pharmaceuticals using structure-based drug design. The Company's products are used for the treatment of immunological, viral, and cardiovascular diseases and disorders. BioCryst's lead immunological drug program targets T-cell proliferative disorders.

In the past 52 weeks, BioCryst Pharmaceuticals share prices have been bracketed by a low of $1.08 and a high of $5.95 and are now at $2.00, 85% above that low price. In the last five trading sessions, the 50-day moving average (MA) has fallen 2.1% while the 200-day MA has remained constant.


BioCryst Pharmaceuticals has overhead space with shares priced $2.00, or 40.0% below the average consensus analyst price target of $3.33. BioCryst Pharmaceuticals shares should first meet resistance at the 200-day moving average (MA) of $4.08 and find additional resistance at the 50-day MA of $4.09.

SmarTrend is monitoring the recent change of momentum in BioCryst Pharmaceuticals. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of BioCryst Pharmaceuticals in search of a potential trend change.

Write to Chip Brian at cbrian@mysmartrend.com --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup

[ Back To TMCnet.com's Homepage ]


Upcoming Events



LATEST VIDEOS

DOWNLOAD CENTER

UPCOMING WEBINARS

MOST POPULAR STORIES





Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

IMPORTANT

SUBSCRIPTIONS


Subscribe to our FREE eNewsletters
SUBMIT

STAY CURRENT YOUR WAY

© 2013 Technology Marketing Corporation. All rights reserved.